November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment
Jul 4, 2024, 14:15

Evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment

ESMO Open shared a post on X:

Hot off the press: Francesco Schettini et al. analyze the clinical and biological evolution of HR+/HER2- breast cancer during exposure to neoadjuvant chemotherapy and endocrine treatment.

Image

Proceed to the article.
Source: ESMO Open/X